Patents by Inventor Rakeshwar Bandichhor

Rakeshwar Bandichhor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR THE CONTINUOUS MANUFACTURE OF STATINS
    Publication number: 20230026095
    Abstract: The present invention relates to process for the continuous manufacture of Statins or salts thereof. The present invention relates to process for the continuous manufacture of Atorvastatin or a salt thereof. The present invention relates to a continuous manufacturing process for the crystallization of Atorvastatin calcium. The present invention also relates to a continuous manufacturing process for the crystallization of Atorvastatin calcium Form I.
    Type: Application
    Filed: November 27, 2020
    Publication date: January 26, 2023
    Inventors: Jaganadha Rao VELAGA, Sahil GUPTA, Manohar VENKATACHALAM, Suhas JAWLEKAR, Srividya RAMAKRISHNAN, Naga Lakshmi Ramana SUSARLA, Rajeev Rehani BUDHDEV, Rakeshwar BANDICHHOR, Mohammed Yakoob SARDAR, Jerome GNANAPRAKASAM, Ravi Kumar G
  • Process for preparation of eribulin and intermediates thereof
    Patent number: 11059799
    Abstract: The present application relate to a process for preparation of 4-Methylene tetrahydrofuran compound of formula II, which is useful as an intermediate for the preparation of halichondrin B analogues such as Eribulin.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: July 13, 2021
    Assignee: DR. REDDY'S LABORATORIES LIMITED.
    Inventors: Sudhir Sai, Debjit Basu, Kumar Sarvesh, Uday Kumar Neelam, Amit Kumar Mandal, Rakeshwar Bandichhor, Vilas Hareshwar Dahanukar
  • PROCESS FOR THE PREPARATION OF ROXADUSTAT AND ITS INTERMEDIATES
    Publication number: 20200299242
    Abstract: The present invention provides the process for the preparation of Roxadustat and its intermediates. Another aspect of the present invention provides a process for preparation of ethyl-5-(2-butoxycarbonyl)-4-phenoxyphenyl) oxazole-4-carboxylate of the formula (X) and its use in the preparation of Roxadustat. Another aspect of the present invention provides a process for the preparation of ethyl-4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylate of the formula (XIII) and its use in the preparation of Roxadustat.
    Type: Application
    Filed: November 30, 2018
    Publication date: September 24, 2020
    Inventors: Amarnath Reddy LEKKALA, Jaydeepkumar DAHYABHAI LILAKAR, Mohammad AASEEF, Rehani Rajeev BUDHDEV, Sekhar Munaswamy NARIYAM, Rakeshwar BANDICHHOR, Sharad Santu PACHORE, Soma Rani SARKAR, Babu IRENI, Deep MALA, Kiran Kumar DONIPARTHI, Venkata Krishna Rao BADARLA
  • Solid state forms of dasatinib and processes for their preparation
    Patent number: 10464933
    Abstract: The present invention provides crystalline form of (R)-propylene glycol solvate of dasatinib and crystalline form of (S)-propylene glycol solvate of dasatinib.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: November 5, 2019
    Assignee: DR. REDDY'S LABORATORIES LIMITED
    Inventors: Satyanarayana Thirunahari, Anish Anil Gupta, Srividya Ramakrishnan, Sonawane Swapnil, Rakeshwar Bandichhor, Srinivasula Reddy Lakkireddy
  • PROCESS FOR PREPARATION OF ERIBULIN AND INTERMEDIATES THEREOF
    Publication number: 20190177291
    Abstract: The present application relate to a process for preparation of 4-Methylene tetrahydrofuran compound of formula II, which is useful as an intermediate for the preparation of halichondrin B analogues such as Eribulin.
    Type: Application
    Filed: May 25, 2017
    Publication date: June 13, 2019
    Inventors: Sudhir Sai, Debjit Basu, Kumar Sarvesh, Uday Kumar Neelam, Amit Kumar Mandal, Rakeshwar Bandichhor, Vilas Hareshwar Dahanukar
  • Pharmaceutical compositions comprising boronic acid compounds
    Patent number: 10293048
    Abstract: A pharmaceutical composition and preparing processes thereof. The composition comprises bortezomib or pharmaceutically acceptable salt or solvate thereof, tromethamine and an organic carboxylic acid, and the pH of the composition is from about 3.0 to 6.0.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: May 21, 2019
    Assignee: DR. REDDY'S LABORATORIES LIMITED
    Inventors: Navin Vaya, Harshal Prabhakar Bhagwatwar, Rakeshwar Bandichhor, Nirmal Khati, Riyaz Ahmed Shaik, Rahul Bhise, Yakaswamy Asalla, Rajkumar Bhimrao Shinde
  • SOLID STATE FORMS OF DASATINIB AND PROCESSES FOR THEIR PREPARATION
    Publication number: 20190040054
    Abstract: The present invention provides crystalline form of (R)-propylene glycol solvate of dasatinib and crystalline form of (S)-propylene glycol solvate of dasatinib.
    Type: Application
    Filed: February 3, 2017
    Publication date: February 7, 2019
    Inventors: Satyanarayana THIRUNAHARI, Anish ANIL GUPTA, Srividya RAMAKRISHNAN, Sonawane SWAPNIL, Rakeshwar BANDICHHOR, Srinivasula Reddy LAKKIREDDY
  • Preparation of crystalline bazedoxifene and its salts
    Patent number: 9212172
    Abstract: Aspects of the present disclosure include crystalline bazedoxifene free base, crystalline bazedoxifene acetate Form D, and processes for their preparation. The drug compound having the adopted name “bazedoxifene acetate” has a chemical name 1-[4-(2-azepan-1-yl-ethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol acetic acid, and has the chemical structure shown below as Formula I.
    Type: Grant
    Filed: September 14, 2011
    Date of Patent: December 15, 2015
    Assignees: DR. REDDY'S LABORATORIES LIMITED, DR. REDDY'S LABORATORIES, INC.
    Inventors: Sundra Lakshmi Kanniah, Rajesham Boge, Peddireddy Subbareddy, Lalita Kanwar, Srividya Ramakrishnan, Ramya Kumar, Rakeshwar Bandichhor, Amarnath Reddy Lekkala, Ravi Kumar Mylavarapu, Vagwala Raghunath
  • PHARMACEUTICAL COMPOSITIONS COMPRISING BORONIC ACID COMPOUNDS
    Publication number: 20150051172
    Abstract: A pharmaceutical composition and preparing processes thereof. The composition comprises bortezomib or pharmaceutically acceptable salt or solvate thereof, tromethamine and an organic carboxylic acid, and the pH of the composition is from about 3.0 to 6.0.
    Type: Application
    Filed: March 1, 2013
    Publication date: February 19, 2015
    Inventors: Navin Vaya, Harshal Prabhakar Bhagwatwar, Rakeshwar Bandichhor, Nirmal Khati, Riyaz Ahmed Shaik, Rahul Bhise, Yakaswamy Asalla, Rajkumar Bhimrao Shinde
  • PREPARATION OF CRYSTALLINE BAZEDOXIFENE AND ITS SALTS
    Publication number: 20130225805
    Abstract: Aspects of the present disclosure include crystalline bazedoxifene free base, crystalline bazedoxifene acetate Form D, and processes for their preparation. The drug compound having the adopted name “bazedoxifene acetate” has a chemical name 1-[4-(2-azepan-1-yl-ethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol acetic acid, and has the chemical structure shown below as Formula I.
    Type: Application
    Filed: September 14, 2011
    Publication date: August 29, 2013
    Applicants: DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES LTD.
    Inventors: Sundra Lakshmi Kanniah, Rajesham Boge, Peddireddy Subbareddy, Lalita Kanwar, Srividya Ramakrishnan, Ramya Kumar, Rakeshwar Bandichhor, Amarnath Reddy Lekkala, Ravi Kumar Mylavarapu, Vagwala Raghunath